The hallmark of "Il2-interferon (ILFN42)/ hepatocyte-stimulating factor/interleukin 6" gene expression is its inducibility in different types of human cells (fibroblasts, monocytes, epithelial cells, and endothelial cells) by different stimuli, which include cytokines such as tumor necrosis factor, interleukin 1 (IL-1) and platelet-derived growth factor, different viruses, and bacterial products such as endotoxin. The activation by cytokines, viruses, and second messenger agonists of the IFN-.8 promoter linked to the bacterial chloramphenicol acetyltransferase (CAT) gene was studied after transfection into HeLa cells. A chimeric gene containing IFN-f32 DNA from -1180 to + 13 linked to the CAT gene was inducible %10-fold by phorbol 12-myristate 13-acetate (PMA), followed, in decreasing order, by pseudorabies and Sendai viruses (7-to 11-fold each); serum (6-to 9-fold); the cytokines tumor necrosis factor, IL-1, and epidermal growth factor (3-to 5-fold each); the cAMP agonists BrcAMIP and forskolin and the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (2-to 6-fold each); poly(I) poly(C) (2-to 4-fold); 1,2-diacylglycerol and the calcium ionophore A23187 (1.5-to 2-fold each). Bacterial endotoxin did not activate this iFN-.82/CAT fusion gene in HeLa cells. Deletion of the 5' boundary of the IFN-132 DNA from -1180 to -596 in the fusion gene preserved its activation by IL-1, tumor necrosis factor, epidermal growth factor, serum, pseudorabies, and Sendai viruses and by PMA, BrcAMP, and forskolin; deletion to -225 led to a small reduction (by a factor of 1.5-2) in the responsiveness to serum, PMA, and Sendai virus but not to the other inducers; a further deletion to -112 greatly reduced all responsiveness. Thus, the region between -225 and -113 in IFN-fi2, which contains DNA motifs similar to the regulatory elements in the human c-fos gene, appears to contain the major cis-acting regulatory elements responsible for the activation of the IFN-62 promoter by several different cytokines, viruses, and second messenger agonists.
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The human cytokines variously termed 82-interferon (IFN-I2), hepatocyte-stimulating factor, B-cell differentiation factor 2, hybridoma or plasmacytoma growth factor, T-cell activating factor, colony-stimulating factor 309, and interleukin 6 represent polypeptides derived from the same human gene located on chromosome 7p2l (reviewed in refs. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] .
Human fibroblasts can be induced to secrete multiple forms of IFN-p,2 phosphoglycoproteins in the size range 23-30 kDa: a triplet of molecular mass -25 kDa and another triplet of molecular mass 30 kDa (7, 8, 11, 13) . Induced human monocytes secrete a similar array of IFN-/32 proteins except that the 28-to 30-kDa monocytic proteins are poorly phosphorylated (8, 11, 12) . Differential N-and O-glycosylation (the 23-to 25 -kDa forms are 0-glycosylated; the 28-to forms are 0-and N-glycosylated) as well as differential phosphorylation appear to contribute to the observed heterogeneity of the secreted IFN-P32 proteins.
IFN-P2 gene expression is enhanced in several different
types of cells (fibroblasts, monocytes, keratinocytes, other epithelial, and mesenchymal cells) in response to a wide range of "noxious" stimuli, such as bacterial lipopolysaccharide (endotoxin), virus infections, and inflammationassociated cytokines like tumor necrosis factor (TNF), interleukin 1 (IL-1), and platelet-derived growth factor (reviewed in refs. 4-11, 16, 17) . Transcription of the IFN-182 gene can be enhanced through the diacyiglycerol-, Ca2+-, and the cAMP-activated pathways (18) (19) (20) . The mechanisms that govern the regulation of expression of the IFN-,32 gene seem remarkably adapted to the primary function of IFN-f32, which appears to be communication between damaged tissues and the hepatocyte, as IFN-,82 is a key mediator of the plasma protein response to tissue injury (the "acute-phase" response) (21) (22) (23) (24) .
The regulation of IFN-32 gene expression in human diploid fibroblasts has been studied in our laboratory at the level of protein secretion (7) (8) (9) (10) (11) , steady-state mRNA expression (5, 6, 9, 10, (16) (17) (18) , and nuclear transcription (18, 19 (27) by fusing the bacterial CAT transcription unit [containing the CAT coding region, the simian virus 40 (SV40) small T intron, and the SV40 early poly(A) site] from pSV2-CAT (28) downstream from the IFN-p2 promoter (from -1180 to + 13) (Fig. 1) as an internal transfection marker. The HeLa cell cultures were exposed to the DNA-calcium phosphate coprecipitate for 16 hr. The cultures were then washed extensively with serum-free medium and incubated for another 16 hr in serum-free medium containing 0.01% bovine serum albumin (Miles) with or without other reagents as potential inducers. Cytoplasmic extracts containing equal amounts of protein as measured by the Bradford method (31) were assayed for CAT activity (100-150 ,ug per assay) as described by Gorman et al. (28) (except that 0.1 ,uCi of [14C]chloramphenicol was used in each assay; 1 Ci = 37 GBq) and for NPT II activity ,g per assay) as described by Platt and Yang (32) ., Activation of the Endogenous IFN-A32 Gene in HeLa Cells.
The activation of the endogenous IFN-/32 gene in HeLa cells by the different inducers was monitored by immunoblot analyses of the secreted IFN-f32 species with a rabbit antiserum to E. coli-derived recombinant IFN-P2 as a probe (8) and by measuring the ability of the secreted HeLa-cellderived IFN-p2 to enhance a1-antichymotrypsin synthesis and secretion in human hepatoma Hep3B2 cells (American Type Culture Collection; catalogue no. 8064) as described elsewhere (8, 9 The inclusion of 10% serum during the induction resulted in cultivated throughout in medium containing lo0 fetal bovine serum a 6-fold increase in CAT expression. Sendai and pseudoraand were induced with various reagents 16 hr after transfection. CAT and NPT II enzyme activities were assayed in cytoplasmic extracts the greatest increase in CAT expression (7-to 12-fold); prepared after a 16-hr incubation with the appropriate inducers. 1-Acetyl and 3-acetyl chloramphenicol derivatives (AcCM) formed poly(I)-poly(C) and the cytokines IL-1, TNF, and EGF in the CAT assays were resolved from unreacted chloramphenicol enhanced CAT expression 3-to 4-fold; a combination of (CM) by TLC and detected by autoradiography (Upper). (Lower) forskolin, which stimulates adenylate cyclase, and the phosAutoradiogram showing the kanamycin phosphate (Kin) reaction phodiesterase inhibitor isobutylmethylxanthine also proproduct of the NPT II assay as measured in a dot assay. Numbers duced a clear increase in CAT expression (2.7-fold in this denote -fold inductions of CAT expression relative to that in * ) * e * uninduced cells (UNIND) normalized to the NPT II activity in each expenyment). In additional expenments, forskolin, isobutylextract. The inducers used were A23187 (2 jAM), dioctanoylglycerol methylxanthine, and BrcAMP alone or in appropriate com-(DiC8) (50 ug/ml, which corresponds to 150 uM), poly(I)-poly(C) binations enhanced CAT expression 2-to 6-fold. CAT (pIpC) (100 ,ug/ml), Sendai virus (SEND) (4 x 107 plaque-forming expression was reproducibly enhanced by 1,2-dioctanoylunits/ml, which corresponds to a multiplicity ofinfection of 10), TNF glycerol (1.5-to 2-fold); however, under these serum-free (50 ng/ml), and IL-la (1 ng/ml).
conditions A23187 appeared unable to activate the IFNp2/CAT fusion gene. Fig. 2 as well as with a combination of forskolin (FORS) (50 jLM) and isobutylmethylxanthine (IMX) (0.5 mM), fetal bovine serum (1o0), EGF (100 ng/ml), pseudorabies virus (PR) (4 x 107 plaque forming units/ml, which corresponds to a multiplicity of infection of 10), and PMA (TPA) (100 ng/ml, which corresponds to 160 nM).
RESULTS
Biochemistry: Ray et al.
Proc. Natl. Acad. Sci. USA 85 (1988) IFN-f32/CAT fusion plasmids containing IFN-f32 DNA from -596 to + 13 (BalI), -225 to +13 (Nhe I), and -112to +13 (Hae III). The four IFN-,32/CAT chimeric constructs (designated -1180, -596, -225, and -112) were used at the same time in each experiment with different inducers (Fig. 4) . Deletion of the 5' boundary of IFN-f32 DNA from -1180 to -596 preserved activation of the chimeric gene by IL-1, TNF, EGF, serum, pseudorabies and Sendai viruses, and PMA (Fig. 4) . Deletion to -225 led to a small (1.5-to 2-fold) but reproducible reduction in the responsiveness to serum, PMA, and Sendai virus but not to TNF, IL-1, EGF, or pseudorabies virus (Fig. 4) . Further deletion to -112 greatly decreased all responsiveness (Fig. 4) . Results similar to those illustrated for TNF and IL-1 in Fig. 4 for their ability to induce the four chimeric genes (data not shown). Thus, the major decrease in inducibility of the IFN-,2 promoter by several different cytokines, viruses, and second messenger agonists is observed when the 5' flanking DNA is trimmed from -225 to -112. In the experiment illustrated in Fig. 4 and in additional experiments, the -112 construct retained some (2-to 3-fold) inducibility in response to pseudorabies virus. This shows that the 112-bp 5' flanking IFN-f32 sequence retains the basic elements required for RNA transcription per se.
Activation of the Endogenous IFN-(32 Gene in HeLa Cells.
Enhanced levels of IFN-/32 derived from the endogenous HeLa gene were observed in medium from cultures transfected with chimeric -112 IFN-P2/CAT constructs and then induced. IFN-,B2 in HeLa cell culture medium was assayed either by immunoblot analyses (Fig. 5 A and B) or by a bioassay based on the ability of IFN-p32 to enhance a,-antichymotrypsin synthesis and secretion in Hep3B2 cells (Fig. 5C ). Fig. 5 transcription factor AP-1 is considered to mediate some of the responses to PMA (33, 34) . This sequence is very similar to the ras responsive element, which also mediates responses to PMA and serum (TGACTAA; ref. 35 ). An AP-1 consensus sequence (TGAGTCA) is present between nucleotides -280 and -274 in the promoter of the IFN-82 gene.
Deletion of the IFN-p2 DNA from -225 to -112 led to a marked decrease in the ability ofall ofthe inducers to activate the chimeric gene. We have previously pointed out that the region from -169 to -124 in IFN-P2 is similar to the serumresponsive enhancer in the human c-fos gene (19) . In addition, the direct repeat sequence present in the human c-fos gene between -97 and -76, which has been demonstrated to be important for basal expression (31) (18) , the transfected fusion gene and the endogenous IFN-f32 gene in HeLa cells respond quite well. The response of the IFN-p32 promoter in the HeLa transfection assay to dioctanoylglycerol and A23187 is particularly lower than that observed in human fibroblasts (18) . Other investigators have reported that a transfected c-fos/CAT chimeric gene responds less well to serum than the endogenous c-fos gene (33) and that A23187 was unable to activate a transfected c-fos construct while the endogenous gene could be readily activated (34) .
In summary, a chimeric CAT gene construct driven by the IFN-B,2 promoter can be activated by different cytokines, viruses, and second messengers in a transient expression system in HeLa cells. The region between -225 and -113 in the IFN-82 promoter is required for this activation. These data suggest that the different stimuli that turn on the IFN-p82 gene utilize biochemical pathways that converge onto this region of the DNA 5' to the IFN-,2 gene.
